stallimycin has been researched along with cysteine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Grokhovsky, SL; Gursky, GV; Leinsoo, TA; Nikolaev, VA; Shafer, RH; Strahan, GA; Surovaya, AN; Zasedatelev, AS; Zhuze, AL | 1 |
Baraldi, PG; Bianchi, N; Bolzati, C; Duatti, A; Gambari, R; Mischiati, C; Piffanelli, A; Romagnoli, R | 1 |
Baraldi, PG; Gambari, R; La Colla, P; Makaeva, R; Nuñez, Mdel C; Pavani, MG; Romagnoli, R; Tabrizi, MA | 1 |
3 other study(ies) available for stallimycin and cysteine
Article | Year |
---|---|
Design of sequence-specific DNA binding ligands that use a two-stranded peptide motif for DNA sequence recognition.
Topics: Aminoglycosides; Antibiotics, Antineoplastic; Base Composition; Base Sequence; Binding Sites; Binding, Competitive; Cysteine; Deoxyribonuclease I; Dinucleotide Repeats; Distamycins; Disulfides; DNA; Drug Design; Models, Chemical; Models, Molecular; Molecular Sequence Data; Netropsin; Nucleic Acid Conformation; Peptides; Protein Binding; Protein Conformation; Repetitive Sequences, Nucleic Acid; Structure-Activity Relationship; Substrate Specificity; Thermodynamics | 1996 |
Synthesis of hybrid distamycin-cysteine labeled with 99mTc: a model for a novel class of cancer imaging agents.
Topics: Cysteine; Distamycins; Humans; Neoplasms; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals | 2000 |
Design, synthesis and in vitro cytotoxicity of a cis-dichloroplatinum (II) complex linked to the minor groove binder stallimycin.
Topics: Antineoplastic Agents; Cell Survival; Chemical Phenomena; Chemistry, Physical; Cisplatin; Cysteine; Dimethyl Sulfoxide; Distamycins; Drug Design; Humans; Indicators and Reagents; Tumor Cells, Cultured | 2003 |